The European Life Sciences Coalition has been launched in Brussels with the aim of strengthening Europe’s life sciences and ...

AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence for durvalumab, ...

Bioxytran has reported positive results from its completed phase 2 trial of ProLectin‑M, showing rapid and sustained viral clearance in subjects with laboratory‑confirmed acute viral infection. The ...

Serac Healthcare has received fast track designation from the US Food and Drug Administration for 99mTc‑maraciclatide, a SPECT‑CT imaging agent intended for the visualisation of inflammation in ...

ALK has announced that its EURneffy 1mg nasal adrenaline spray has received a positive opinion from the Committee for ...

In oncology care, clinical success is defined primarily by time: months or years of survival. Yet for patients living with ...

THX Pharma and Biocodex have entered a strategic licensing agreement covering three rare diseases, with Biocodex acquiring rights to develop and commercialise two drug candidates across multiple ...

Breye Therapeutics has reported promising early clinical findings for its lead oral therapy danegaptide, following a presentation at the Angiogenesis, Exudation and Degeneration 2026 symposium.

Marketing-centric engagement, designed for lower-complexity markets where scale and awareness are priorities. This model ...

emc receives over 40 million visits per year, with 72% of HCPs stating this resource as their first-choice source of medicines information. For a deeper look at the survey findings and its ...

En Carta Diagnostics, a start-up company developing molecular diagnostics kits, has announced that its EC Pocket Lyme test has received Breakthrough Device Designation from the US Food and Drug ...

What began as a convenience play has evolved into something more consequential: a shift in where trust is built; how ...